Status:
COMPLETED
Therapeutic Effects of Berberine in Patients With Type 2 Diabetes
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
25-75 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine whether berberine is effective in the treatment of type 2 diabetes.
Detailed Description
Type 2 diabetes is health threats worldwide. However, treatment of this disease is limited by availability of effective medicines. All of the existing oral hypoglycemic agents have secondary failure a...
Eligibility Criteria
Inclusion
- Clinical diagnosis of type 2 diabetes
- HbA1c \> 7.0% or FBG \> 7.0 mmol/L
- Stable or worsening glycemic control for at least 3 months
Exclusion
- Liver damage
- Kidney damage
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00425009
Start Date
January 1 2004
End Date
December 1 2004
Last Update
January 22 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, China, 200092